The Medicines Company
Novartis eyes $5bn The Medicines Company acquisition – reports
Richard Staines
cardiology, M&A, Novartis, The Medicines Company
0 Comment
X
Novartis eyes $5bn The Medicines Company acquisition – reports
https://pharmaphorum.com/news/novartis-eyes-5bn-the-medicines-company-acquisition-reports/
TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?
Phil Taylor
Amgen, cardiovascular disease, cholesterol, gene silencing, inclisiran, PCSK9 inhibitors, Praluent, Regeneron, Repatha, RNA interference, Sanofi, The Medicines Company
0 Comment
X
TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?
https://pharmaphorum.com/news/tmcs-inclisiran-impresses-at-esc-but-will-it-surpass-pcsk9-rivals/
TMC inches closer to inclisiran approval with long-term safety data
Phil Taylor
cholesterol, inclisiran, The Medicines Company, TMC
0 Comment
X
TMC inches closer to inclisiran approval with long-term safety data
https://pharmaphorum.com/news/tmc-inches-closer-to-inclisiran-approval-with-long-term-safety-data/